Across TCGA pan-cancer cohorts, ZSWIM7 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ZSWIM7 data layer compared with 27 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher ZSWIM7 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZSWIM7 expression acts as an unfavorable survival marker.

PDAC and LUAD are the cancer types where ZSWIM7 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Median	All	0.215	0.542	.047	3	view →
LUAD	DFS	Median	All	0.105	0.888	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: ZSWIM7 tumor-vs-normal RNA expression · all ZSWIM7 data types